This brand name is authorized in Turkey
The drug VASOPLAN contains one active pharmaceutical ingredient (API):
1
Pentoxifylline
UNII SD6QCT3TSU - PENTOXIFYLLINE
|
Pentoxifylline has been shown to increase leukocyte deformability and to inhibit neutrophil adhesion and activation. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
C04AD03 | Pentoxifylline | C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AD Purine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699541030700, 8699541751315 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.